The Barbell Market of 2026: Balancing Gene Therapies With High-Leverage ETFsGlobal Report·Jul 18 at 04:13 AMDV+3.69%BNR+5.03%
Biotech and CXO Clinical Momentum: 7 Core Companies Set for Late-2026 BreakoutsGlobal Report·Jul 9 at 05:02 AMBVS+5.51%ALT+6.86%
Major Insider Move Signals Growing Confidence in Burning Rock BiotechTip Ranks·Jul 2 at 09:03 PMBNR+5.03%
Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141 ADSs for $618,217.72.benzinga_article·Jul 2 at 01:33 PMBNR+5.03%
Burning Rock Biotech Director Purchased Shares Worth Over $6.1MTradingView·Jul 2 at 07:40 AMBNR+5.03%
Burning Rock Biotech director Han Yusheng reports $6.42 million ADS purchasePUBT·Jul 2 at 07:31 AMBNR+5.03%
Burning Rock Announces Founder’s Purchase of Its ADSs | BNR Stock NewsStockTitan·Jul 1 at 10:19 PMBNR+5.03%
Why These High-Flying Stocks Came Back To Earthbenzinga_article·Jun 12 at 07:27 AMBNR+5.03%HERE+3.26%
Options Volatility and Implied Earnings Moves Today, June 09, 2026Tip Ranks·Jun 9 at 06:05 AMSAIL+2.61%SJM+2.31%
Burning Rock Reports First Quarter 2026 Financial Results | BNR Stock NewsStockTitan·Jun 8 at 09:38 PMBNR+5.03%
Burning Rock Publishes 2025 Annual Report on Form 20-F | BNR Stock NewsStockTitan·Apr 27 at 09:45 PMBNR+5.03%
